Cross-genotype AR3-specific neutralizing antibodies confer long-term protection in injecting drug users after HCV clearance

Autor: Merat, Sabrina J., Bru, Camille, van de Berg, Dorien, Molenkamp, Richard, Tarr, Alexander W., Koekkoek, Sylvie, Kootstra, Neeltje A., Prins, Maria, Ball, Jonathan K., Bakker, Arjen Q., de Jong, Menno D., Spits, Hergen, Beaumont, Tim, Schinkel, Janke

Publikováno v: In Journal of Hepatology July 2019 71(1):14-24

Hepatitis C virus Broadly Neutralizing Monoclonal Antibodies Isolated 25 Years after Spontaneous Clearance.

Autor: Merat, Sabrina J.¹, Molenkamp, Richard², Wagner, Koen¹, Koekkoek, Sylvie M.², van de Berg, Dorien¹, Yasuda, Etsuko¹, Böhne, Martino¹, Claassen, Yvonne B.¹, Grady, Bart P.³, Prins, Maria^3,4, Bakker, Arjen Q.¹, de Jong, Menno D.², Spits, Hergen¹, Schinkel, Janke², Beaumont, Tim¹ tbeaumont@aimmtherapeutics.com

Publikováno v: PLoS ONE. 10/24/2016, Vol. 11 Issue 10, p1-18. 18p.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Erratum to: 'Cross-genotype AR3-specific neutralizing antibodies confer long-term protection in injecting drug users after HCV clearance' (J Hepatol 2019; 71(1): 14-24).

Autor: Merat SJ; AIMM Therapeutics, Amsterdam, the Netherlands., Bru C; AIMM Therapeutics, Amsterdam, the Netherlands., van de Berg D; AIMM Therapeutics, Amsterdam, the Netherlands., Molenkamp R; Department of Medical Microbiology, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands., Tarr AW; School of Life Sciences, The University of Nottingham, Nottingham, UK; NIHR Nottingham BRC, Nottingham University Hospitals NHS Trust and the University of Nottingham, Nottingham, UK., Koekkoek S; Department of Medical Microbiology, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands., Kootstra NA; Department of Experimental Immunology, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands., Prins M; Public Health Service of Amsterdam, Amsterdam, the Netherlands; Department of Infectious Diseases, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands., Ball JK; School of Life Sciences, The University of Nottingham, Nottingham, UK; NIHR Nottingham BRC, Nottingham University Hospitals NHS Trust and the University of Nottingham, Nottingham, UK., Bakker AQ; AIMM Therapeutics, Amsterdam, the Netherlands., de Jong MD; Department of Medical Microbiology, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands., Spits H; AIMM Therapeutics, Amsterdam, the Netherlands., Beaumont T; AIMM Therapeutics, Amsterdam, the Netherlands. Electronic address: tbeaumont@aimmtherapeutics.com., Schinkel J; Department of Medical Microbiology, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands. Electronic address: J.Schinkel@amc.uva.nl.

Publikováno v: Journal of hepatology [J Hepatol] 2020 Oct; Vol. 73 (4), pp. 999-1000. Date of Electronic Publication: 2020 Aug 01.